News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,536 Results
Type
Article (48288)
Company Profile (300)
Press Release (702938)
Multimedia
Podcasts (113)
Webinars (18)
Section
Business (212019)
Career Advice (2488)
Deals (36338)
Drug Delivery (123)
Drug Development (84889)
Employer Resources (180)
FDA (17300)
Job Trends (15412)
News (359577)
Policy (34237)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2784)
Accelerated approval (33)
Adcomms (28)
Allergies (146)
Alliances (51217)
ALS (178)
Alzheimer's disease (1726)
Antibody-drug conjugate (ADC) (330)
Approvals (17532)
Artificial intelligence (528)
Autoimmune disease (157)
Automation (38)
Bankruptcy (370)
Best Places to Work (11948)
BIOSECURE Act (21)
Biosimilars (197)
Biotechnology (196)
Bladder cancer (162)
Brain cancer (58)
Breast cancer (649)
Cancer (4942)
Cardiovascular disease (430)
Career advice (2112)
Career pathing (40)
CAR-T (295)
CDC (51)
Celiac Disease (2)
Cell therapy (772)
Cervical cancer (37)
Clinical research (72264)
Collaboration (1746)
Company closure (4)
Compensation (1151)
Complete response letters (59)
COVID-19 (2854)
CRISPR (97)
C-suite (837)
Cystic fibrosis (148)
Data (6249)
Decentralized trials (2)
Denatured (29)
Depression (144)
Diabetes (512)
Diagnostics (6901)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (252)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (234)
Earnings (93565)
Editorial (62)
Employer branding (21)
Employer resources (159)
Events (120647)
Executive appointments (989)
FDA (20454)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1498)
Gene editing (209)
Generative AI (46)
Gene therapy (628)
GLP-1 (1042)
Government (4927)
Grass and pollen (7)
Guidances (385)
Healthcare (19623)
HIV (57)
Huntington's disease (49)
IgA nephropathy (84)
Immunology and inflammation (276)
Immuno-oncology (56)
Indications (104)
Infectious disease (3127)
Inflammatory bowel disease (197)
Inflation Reduction Act (15)
Influenza (113)
Intellectual property (246)
Interviews (436)
IPO (16985)
IRA (54)
Job creations (3805)
Job search strategy (1732)
JPM (61)
Kidney cancer (15)
Labor market (83)
Layoffs (600)
Leadership (37)
Legal (8288)
Liver cancer (97)
Longevity (15)
Lung cancer (666)
Lymphoma (378)
Machine learning (42)
Management (62)
Manufacturing (804)
MASH (169)
Medical device (14254)
Medtech (14308)
Mergers & acquisitions (20421)
Metabolic disorders (1318)
Multiple sclerosis (160)
NASH (21)
Neurodegenerative disease (334)
Neuropsychiatric disorders (93)
Neuroscience (3006)
Neurotech (1)
NextGen: Class of 2026 (6850)
Non-profit (4718)
Now hiring (65)
Obesity (630)
Opinion (301)
Ovarian cancer (168)
Pain (210)
Pancreatic cancer (230)
Parkinson's disease (296)
Partnered (34)
Patents (496)
Patient recruitment (491)
Peanut (60)
People (60290)
Pharmaceutical (67)
Pharmacy benefit managers (29)
Phase 1 (22685)
Phase 2 (31675)
Phase 3 (23678)
Pipeline (5163)
Policy (306)
Postmarket research (2693)
Preclinical (9531)
Press Release (67)
Prostate cancer (246)
Psychedelics (53)
Radiopharmaceuticals (284)
Rare diseases (879)
Real estate (6216)
Recruiting (72)
Regulatory (25563)
Reports (52)
Research institute (2541)
Resumes & cover letters (413)
Rett syndrome (28)
RNA editing (18)
RSV (83)
Schizophrenia (154)
Series A (248)
Series B (194)
Service/supplier (13)
Sickle cell disease (103)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (3798)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (92)
The Weekly (82)
Vaccines (1074)
Venture capital (90)
Weight loss (413)
Women's health (87)
Worklife (19)
Date
Last 7 days (616)
Last 30 days (2155)
Last 365 days (30663)
2026 (2905)
2025 (31117)
2024 (36181)
2023 (41159)
2022 (52395)
2021 (57008)
2020 (55481)
2019 (48273)
2018 (36396)
2017 (33562)
2016 (33016)
2015 (39039)
2014 (32777)
2013 (27825)
2012 (30063)
2011 (30664)
2010 (28961)
Location
Africa (871)
Alabama (85)
Alaska (7)
Arizona (318)
Arkansas (13)
Asia (41981)
Australia (6974)
California (11320)
Canada (3278)
China (1134)
Colorado (476)
Connecticut (475)
Delaware (335)
Europe (92148)
Florida (1671)
Georgia (361)
Hawaii (3)
Idaho (62)
Illinois (871)
India (64)
Indiana (520)
Iowa (23)
Japan (423)
Kansas (126)
Kentucky (38)
Louisiana (27)
Maine (83)
Maryland (1395)
Massachusetts (8144)
Michigan (323)
Minnesota (633)
Mississippi (6)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (80)
New Jersey (3025)
New Mexico (28)
New York (2990)
North Carolina (1516)
North Dakota (9)
Northern California (5508)
Ohio (335)
Oklahoma (21)
Oregon (42)
Pennsylvania (2287)
Puerto Rico (22)
Rhode Island (47)
South America (1238)
South Carolina (65)
South Dakota (1)
Southern California (4406)
Tennessee (173)
Texas (1749)
United States (40282)
Utah (341)
Vermont (1)
Virginia (265)
Washington D.C. (81)
Washington State (923)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
751,536 Results for "first databank inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026
February 4, 2026
·
2 min read
Rare diseases
FDA Greenlights First Gene Therapy for Rare Pediatric Disease
Backed by Italy-based Fondazione Telethon ETS, Waskyra, for Wiskott-Aldrich syndrome, is the first gene therapy from a non-profit sponsor to win FDA approval.
December 10, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026
October 31, 2025
·
15 min read
Press Releases
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
February 1, 2026
·
8 min read
Press Releases
Aprea Therapeutics Announces Early Clinical Proof-Of-Concept in the Ongoing ACESOT-1051 Dose-Escalation Trial Evaluating WEE1 Inhibitor APR-1051, Including Partial Response Observed on First Scan
January 29, 2026
·
7 min read
Press Releases
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer
December 23, 2025
·
7 min read
Press Releases
All Approved Indications of Five Akeso’s Innovative Drugs Included in China’s Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs
December 8, 2025
·
7 min read
Press Releases
Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase
December 12, 2025
·
2 min read
Press Releases
HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health
November 11, 2025
·
7 min read
Press Releases
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a First-line Treatment for Diffuse Large B-Cell Lymphoma
January 5, 2026
·
9 min read
1 of 75,154
Next
